Oxford Biomedica plc (OXB.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 690.56M |
| Enterprise Value | 741.8M |
| P/E Ratio | -16.06 |
| PEG Ratio | 2.26 |
| Price/Sales Ratio | 3.84 |
| Price/Book Ratio | 11.56 |
| Enterprise/Revenue | 4.32 |
| Enterprise/EBITDA | -55.15 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.23 |
| Operating Margin | -0.16 |
AD
Management Effectiveness
| Return On Assets | -0.14 |
| Return On Equity | -0.55 |
Income Statement
| Revenue | 168.74M |
| Revenue/Share | 1.45 |
| Gross Profit | 65.98M |
| EBITDA | -9.12M |
| Net Income | -30.13M |
| Diluted EPS | -0.27 |
Balance Sheet
| Total Cash | 75.28M |
| Total Cash/Share | 0.62 |
| Total Debt | 158.64M |
| Total Debt/Equity | 2.73 |
| Current Ratio | 2.21 |
| Book Value Per Share | 0.48 |
Price History
| 52-Week Change | -9.9 |
| 52-Week High | 962 |
| 52-Week Low | 420 |
| Moving Average 50 Days | 503 |
| Moving Average 200 Days | 587 |
Statistics
| Average Volume | 546,194 |
| Shares Outstanding | 121.43M |
| % Held by Institutions | 3.14 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
| Last Split Date | May 30, 2018 |
AD
